- Elise Brownell
- Senior Vice President, Operations and Project Management
- Amarantus Bioscience Holdings, United States
Elise Brownell, PhD. has spent the last 35 years in the bio/pharmaceutical arena where she has played key roles in Discovery, Development and Opportunity Assessment to drive innovation. After completing her doctorate, Elise’s career started at SUNY Stony Brook where she made discoveries relating to genetic evolution in the great apes. She continued her interest in comparative molecular biology during her tenure at Frederick Cancer Research Facility and expanded her facility with molecular genetics while in various functions at Bayer Healthcare. She played a pivotal role in directing discovery research in the areas of asthma, allergy, and immunology and continued her dedication to innovation by managing extramural collaborations for Bayer’s Biotechnology unit. Her efforts were widely recognized by promotion to Director, Project Management, where she led global cross-functional teams to bring several of Bayer’s biopharmaceuticals from bench to clinic. Her award winning performance at Bayer was followed by becoming a member of the founding team of a venture-backed spin out (Aerovance, Inc), where she became head of project management. During her tenure as Senior Director, Aerovance garnered over $ 60 MUSD, completed six clinical trials in 3.5 years, and built a right-sized matrixed organization. Currently, Dr. Brownell serves as Senior Vice President of Operations and Project Management at Amarantus Bioscience Holdings, Inc. where she oversees all development programs across a diverse therapeutics and diagnostics portfolio.